Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy M Gulick

Showing results (71-80 of 155) with videos related to

Pageof 16
Sort By:
Transfusion|November 20, 2020
Blood component utilization in COVID-19 patients in New York City: Transfusions do not follow the curveRobert A DeSimone, Victoria A Costa, Kathleen Kane, et al.
Journal of Clinical Microbiology|June 5, 2009
Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virionsNoriaki Hosoya, Zhaohui Su, Timothy Wilkin, et al.
AIDS (London, England)|December 29, 2004
Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group studyDavid W Haas, Heather J Ribaudo, Richard B Kim, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 25, 2007
Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095)Cecilia M Shikuma, Yang Yang, Marshall J Glesby, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 19, 2013
Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysisHeather J Ribaudo, Kimberly Y Smith, Gregory K Robbins, et al.
Open Forum Infectious Diseases|September 1, 2020
COVID-19 in Hospitalized Adults With HIVKate Stoeckle, Carrie D Johnston, Deanna P Jannat-Khah, et al.
Journal of Virology|April 12, 2012
Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressuresAthe M N Tsibris, Zixin Hu, Roger Paredes, et al.
AIDS (London, England)|April 13, 2004
Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up studyCharles Hicks, Martin S King, Roy M Gulick, et al.
Journal of Biomolecular Structure & Dynamics|March 18, 2021
Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infectionDennis C Copertino, Bruno C Casado Lima, Rodrigo R R Duarte, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2011
Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivityTimothy J Wilkin, Mathew Bidwell Goetz, Robert Leduc, et al.
Pageof 16

Showing results (71-80 of 155) with videos related to

Sort By:
Pageof 16
Transfusion|November 20, 2020
Blood component utilization in COVID-19 patients in New York City: Transfusions do not follow the curveRobert A DeSimone, Victoria A Costa, Kathleen Kane, et al.
Journal of Clinical Microbiology|June 5, 2009
Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virionsNoriaki Hosoya, Zhaohui Su, Timothy Wilkin, et al.
AIDS (London, England)|December 29, 2004
Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group studyDavid W Haas, Heather J Ribaudo, Richard B Kim, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 25, 2007
Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095)Cecilia M Shikuma, Yang Yang, Marshall J Glesby, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 19, 2013
Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysisHeather J Ribaudo, Kimberly Y Smith, Gregory K Robbins, et al.
Open Forum Infectious Diseases|September 1, 2020
COVID-19 in Hospitalized Adults With HIVKate Stoeckle, Carrie D Johnston, Deanna P Jannat-Khah, et al.
Journal of Virology|April 12, 2012
Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressuresAthe M N Tsibris, Zixin Hu, Roger Paredes, et al.
AIDS (London, England)|April 13, 2004
Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up studyCharles Hicks, Martin S King, Roy M Gulick, et al.
Journal of Biomolecular Structure & Dynamics|March 18, 2021
Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infectionDennis C Copertino, Bruno C Casado Lima, Rodrigo R R Duarte, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2011
Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivityTimothy J Wilkin, Mathew Bidwell Goetz, Robert Leduc, et al.
Pageof 16